Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines

• Главные авторы: Maria Rosario Z. Capeding (Автор), Maria Liza Antoinette M. Gonzales (Автор), Mandeep Singh Dhingra (Автор), Naveena Aloysia D'Cor (Автор), Venkat Jayanth Midde (Автор), Badri Narayan Patnaik (Автор), Yaël Thollot (Автор), Eric Desauziers (Автор)
• Формат: ‌
• Опубликовано: Taylor & Francis Group, 2017-10-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

The killed bivalent (O1 and O139) whole cell oral cholera vaccine (OCV) (Shanchol™) was first licensed in India in 2009 and World Health Organization pre-qualified in 2011. We assessed the safety and immunogenicity of this OCV in the Philippines. This was a phase IV, single-arm, descriptive, open-la...